Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Jagroop

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Vascular Surgery|February 21, 2002
Regarding "Heparin modulates integrin function in human platelets"D P Mikhailidis, I A Jagroop
Current Drug Targets|July 24, 2001
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disordersI A Jagroop, D P Mikhailidis
Platelets|October 13, 2000
Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofurylI A Jagroop, D P Mikhailidis
Journal of Human Hypertension|September 12, 2000
Angiotensin II can induce and potentiate shape change in human platelets: effect of losartanI A Jagroop, D P Mikhailidis
American Heart Journal|June 1, 1996
Unstable anginaD P Mikhailidis, I A Jagroop
Journal of Internal Medicine|March 30, 1999
Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humansD P Mikhailidis, I A Jagroop
British Journal of Haematology|December 21, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseI A Jagroop, D P Mikhailidis
Circulation|October 27, 1998
Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modalityI A Jagroop, D P Mikhailidis
Platelets|June 28, 2006
Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery diseaseD P Mikhailidis, I A Jagroop
International Angiology : a Journal of the International Union of Angiology|July 10, 1998
Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in hypercholesterolaemic rabbitI A Jagroop, D P Mikhalildis
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Vascular Surgery|February 21, 2002
Regarding "Heparin modulates integrin function in human platelets"D P Mikhailidis, I A Jagroop
Current Drug Targets|July 24, 2001
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disordersI A Jagroop, D P Mikhailidis
Platelets|October 13, 2000
Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofurylI A Jagroop, D P Mikhailidis
Journal of Human Hypertension|September 12, 2000
Angiotensin II can induce and potentiate shape change in human platelets: effect of losartanI A Jagroop, D P Mikhailidis
American Heart Journal|June 1, 1996
Unstable anginaD P Mikhailidis, I A Jagroop
Journal of Internal Medicine|March 30, 1999
Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humansD P Mikhailidis, I A Jagroop
British Journal of Haematology|December 21, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseI A Jagroop, D P Mikhailidis
Circulation|October 27, 1998
Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modalityI A Jagroop, D P Mikhailidis
Platelets|June 28, 2006
Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery diseaseD P Mikhailidis, I A Jagroop
International Angiology : a Journal of the International Union of Angiology|July 10, 1998
Anplag, a selective 5-HT2 receptor antagonist, reduces stenosis induced by balloon injury in hypercholesterolaemic rabbitI A Jagroop, D P Mikhalildis
Pageof 4